Peptide Research Overview
Ipamorelin is a selective growth hormone secretagogue pentapeptide developed for investigating ghrelin receptor modulation in controlled laboratory environments. This synthetic peptide demonstrates selective binding properties at ghrelin receptors, offering researchers at Stroid UK Shop a valuable tool for examining growth hormone axis function without the cortisol or prolactin elevation observed with other secretagogues in preclinical models.
The compound’s molecular structure enables researchers to study selective growth hormone release mechanisms whilst maintaining stability under standard laboratory conditions. Research teams investigating peptide pharmacology can analyse this pentapeptide’s unique selectivity profile through established protocols designed for peptides that modulate endogenous hormone pathways. The compound has progressed through Phase II clinical trials for post-surgical ileus, providing researchers with published data for comparative analysis.
Laboratory Applications
Research applications include investigating ghrelin receptor agonism, growth hormone pulsatility studies, and examining selective secretagogue properties in cell culture systems. Scientists can study the compound’s effects on growth hormone release patterns whilst evaluating its minimal impact on other pituitary hormones compared to broader-acting secretagogues available through our ipamorelin peptide collection.
The pentapeptide structure allows researchers to examine structure-activity relationships within the ghrelin receptor family, whilst its selectivity profile enables comparative studies with other growth hormone releasing compounds. Advanced research teams can investigate the compound’s stability characteristics and receptor binding kinetics through established analytical methods. Metabolic research laboratories can examine this peptide’s effects on growth hormone axis modulation alongside complementary compounds from our SARMs research collection for comprehensive endocrine studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| CAS Number | 170851-70-4 |
| Molecular Weight | 711.85 g/mol |
| Classification | Growth hormone secretagogue pentapeptide |
| Storage | Lyophilised: -20°C |
| Manufacturer | Driada Medical |
Research Compliance
This ipamorelin preparation is manufactured by Driada Medical exclusively for in-vitro research applications. The compound is not intended for human consumption, clinical use, or any application outside controlled laboratory research. Researchers must ensure compliance with institutional guidelines and applicable regulations when studying this growth hormone secretagogue peptide.
